OR (95 % CI), all patients, n = 3054 | P value | OR (95 % CI), hospital survivors, n = 2963 | P value | |
---|---|---|---|---|
Age | 1.01 (1.00–1.02) | 0.019 | 1.01 (1.00–1.02) | 0.019 |
NIHSS at admission | ||||
≤ 5 | Reference | Reference | ||
6–10 | 2.75 (2.28–3.33) | < 0.001 | 2.83 (2.34–3.43) | < 0.001 |
11–15 | 8.01 (5.67–11.31) | < 0.001 | 8.32 (5.86–11.83) | < 0.001 |
16–20 | 9.65 (6.32–14.74) | < 0.001 | 11.07(7.06–17.36) | < 0.001 |
> 20 | 7.62 (5.48–10.60) | < 0.001 | 19.15 (12.01–30.53) | < 0.001 |
Diabetes mellitus | 1.30 (1.10–1.53) | 0.002 | 1.34 (1.13–1.58) | 0.001 |
Leukocytosis (> 10 × 109 cells/L) at admission | 1.46 (1.19–1.80) | < 0.001 | 1.55 (1.25–1.92) | < 0.001 |
Intravenous thrombolysis | 0.53 (0.38–0.74) | < 0.001 | 0.49 (0.34–0.71) | < 0.001 |